Project: Biopharmaceuticals Production and Development Acceleration by ProteoNic and Daresbury Proteins
Acronym | ProDares (Reference Number: 115731) |
Duration | 01/10/2021 - 01/10/2024 |
Project Topic | Now biophamarmaceuticals production uses separate product development and product manufacture processes. We will combine complementary technologies from ProteoNic and Daresbury Proteins to provide an overarching technology pathway for rapid, scalable, highly efficient and cost-effective production and development of difficult-to-express biopharmaceuticals. The project also will, as main societal and economic showcase, generate new proteins based on recently developed SARS-CoV-2 antibodies. |
Network | Eurostars 2 |
Call | Eurostars Cut–off 15 |
Project partner
Number | Name | Role | Country |
---|---|---|---|
1 | Daresbury Proteins | Partner | United Kingdom |
2 | ProteoNic | Coordinator | Netherlands |